SCHEMBL29920801

SCHEMBL29920801

c1ccc(Oc2cccc(NCc3ncc[nH]3)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.68
GRK2 P25098 4/20 0.56
CACNA1B Q00975 5/20 0.49
ROCK2 O75116 2/20 0.44
KLK1 P06870 1/20 0.44
KLK5 Q9Y337 1/20 0.44
FFAR1 O14842 2/20 0.43
F2 P00734 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KDR P35968 1/20 0.41
MITF O75030 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164681 1.00 TAAR1 (0.68) TAAR1GRK2CACNA1BROCK2KLK1
SCHEMBL3164273 0.86 TAAR1 (0.63) TAAR1GRK2ROCK2FFAR1F2
SCHEMBL3171172 0.85 TAAR1 (0.61) TAAR1GRK2ROCK2KLK1KLK5
SCHEMBL2472175 0.85 TAAR1 (0.61) TAAR1GRK2ROCK2KLK1KLK5
SCHEMBL3166154 0.82 TAAR1 (1.00) TAAR1GRK2ROCK2KLK1KLK5
SCHEMBL13451067 0.77 TAAR1 (0.67) TAAR1GRK2ROCK2KLK1KLK5
SCHEMBL3155469 0.77 TAAR1 (0.67) TAAR1KLK1KLK5ALDH1A1KDM4E
SCHEMBL3171445 0.77 TAAR1 (0.67) TAAR1KLK1KLK5ALDH1A1KDM4E
SCHEMBL2473036 0.77 TAAR1 (0.67) TAAR1GRK2ROCK2KLK1KLK5
SCHEMBL5693016 0.77 TAAR1 (0.67) TAAR1KLK1KLK5ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220280527-A1 TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT PURDUE PHARMA L.P. (US) 2022-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220280527-A1 TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT TAAR1, TAAR5, OPRL1 TAAR1 1/4885GRK2 247/4885CACNA1B 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.